Adverse Event: Clinical Trials

1 trial for Adverse Event, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Adverse Event: new trials by email Literature Review of Adverse Event trials Research Report on Adverse Event

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intramuscular Ketorolac at Two Single-Dose Regimens
Ketorolac Injection 15 mg, Ketorolac Injection 60 mg - Musculoskeletal Pain, Analgesia
Phase 4CompletedWilliam Beaumont Army Medical Center1102020-06-272025-10-15

Narrower conditions

Agnosia (1)  ·  Emergencies (1)  ·  Musculoskeletal Pain (1)

Broader conditions

Disease Attributes (1)  ·  Muscular Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurologic Manifestations (1)  ·  Pain (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Perceptual Disorders (1)  ·  Signs and Symptoms (1)

Interventions

Ketorolac (1)  ·  Ketorolac Tromethamine (1)

Sponsors

William Beaumont Army Medical Center (1)

Countries

United States (1)

Top investigators

Nathaniel J Turner, MPAS (1)